$YIDU TECH(02158.HK) In August last year, the State Council issued guidelines on the AI+ healthcare policy. Many AI healthcare companies have sensed business opportunities, and Yidu Tech is no exception. However, Yidu Tech originated in Beijing and has regional development advantages. By responding to policies, it can quickly capture the grassroots healthcare market in Beijing. Moreover, Beijing was the first to respond to the policy. Recently, Beijing also released the "Several Measures to Support the High-Quality Development of Innovative Pharmaceuticals in Beijing (2026)". Yidu Tech, with its regional advantages, will be the first to benefit.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
